• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病:远不止所见那么简单。

Chronic obstructive pulmonary disease: More than meets the eye.

作者信息

Hatipoğlu Umur

机构信息

Center for Comprehensive Care in Chronic Obstructive Pulmonary Disease, Cleveland Clinic Respiratory Institute, Cleveland, Ohio, USA.

出版信息

Ann Thorac Med. 2018 Jan-Mar;13(1):1-6. doi: 10.4103/atm.ATM_193_17.

DOI:10.4103/atm.ATM_193_17
PMID:29387249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5772102/
Abstract

Chronic obstructive pulmonary disease (COPD) is a major health problem which had not received the attention commensurate with the magnitude of its global burden. This is finally changing with the help of a vibrant community of health-care professionals, public officials, and academic researchers. Advances in characterization of the disease, treatment options, imaging modalities, and better understanding of the comorbidities promise to revolutionize how the disease is managed. COPD should no longer augur despair among physicians and patients.

摘要

慢性阻塞性肺疾病(COPD)是一个重大的健康问题,其全球负担的严重程度尚未得到与其相称的关注。在充满活力的医疗保健专业人员、政府官员和学术研究人员群体的帮助下,这种情况终于在发生改变。在疾病特征描述、治疗选择、成像方式方面取得的进展,以及对合并症的更好理解,有望彻底改变该疾病的管理方式。COPD不应再让医生和患者感到绝望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4611/5772102/6e625107e83c/ATM-13-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4611/5772102/cdb975ffb87f/ATM-13-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4611/5772102/6e625107e83c/ATM-13-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4611/5772102/cdb975ffb87f/ATM-13-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4611/5772102/6e625107e83c/ATM-13-1-g004.jpg

相似文献

1
Chronic obstructive pulmonary disease: More than meets the eye.慢性阻塞性肺疾病:远不止所见那么简单。
Ann Thorac Med. 2018 Jan-Mar;13(1):1-6. doi: 10.4103/atm.ATM_193_17.
2
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.慢性阻塞性肺疾病诊断、管理和预防全球策略:GOLD执行摘要
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
3
Preclinical murine models of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的临床前小鼠模型。
Eur J Pharmacol. 2015 Jul 15;759:265-71. doi: 10.1016/j.ejphar.2015.03.029. Epub 2015 Mar 24.
4
Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients.观察慢性阻塞性肺疾病患者的眼睛:为这些复杂患者进行更好的微血管分析提供机会。
Acta Ophthalmol. 2018 Sep;96(6):539-549. doi: 10.1111/aos.13765. Epub 2018 May 16.
5
The 2017 Global Initiative for Chronic Obstructive Lung Disease Report and Practice Implications for the Respiratory Therapist.《2017年慢性阻塞性肺疾病全球倡议报告及对呼吸治疗师的实践意义》
Respir Care. 2017 Nov;62(11):1492-1500. doi: 10.4187/respcare.05402. Epub 2017 Sep 5.
6
[Chronic obstructive pulmonary disease (COPD) and its future].[慢性阻塞性肺疾病及其未来]
Tuberk Toraks. 2007;55(3):303-18.
7
Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.慢性阻塞性肺疾病的范式:表型、免疫生物学及以血管疾病为重点的治疗
J Investig Med. 2017 Aug;65(6):953-963. doi: 10.1136/jim-2016-000358. Epub 2017 Mar 3.
8
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病。
Lancet. 2017 May 13;389(10082):1931-1940. doi: 10.1016/S0140-6736(17)31222-9. Epub 2017 May 11.
9
A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.一种自我管理方法,在持续的护士支持下,让慢性阻塞性肺疾病(COPD)和合并症患者使用自我启动的行动计划来处理症状:COPE-III 研究方案。
Contemp Clin Trials. 2013 Sep;36(1):81-9. doi: 10.1016/j.cct.2013.06.003. Epub 2013 Jun 14.
10
Comorbidities and their impact on chronic obstructive pulmonary disease.合并症及其对慢性阻塞性肺疾病的影响。
Tuberk Toraks. 2016 Dec;64(4):289-298.

引用本文的文献

1
Unravelling the Therapeutic Potential of Nano-Delivered Functional Foods in Chronic Respiratory Diseases.揭示纳米递呈功能性食品在慢性呼吸道疾病中的治疗潜力。
Nutrients. 2022 Sep 16;14(18):3828. doi: 10.3390/nu14183828.
2
Midkine-Notch2 Pathway Mediates Excessive Proliferation of Airway Smooth Muscle Cells in Chronic Obstructive Lung Disease.中期因子-Notch2信号通路介导慢性阻塞性肺疾病中气道平滑肌细胞的过度增殖
Front Pharmacol. 2022 Jun 14;13:794952. doi: 10.3389/fphar.2022.794952. eCollection 2022.
3
Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.

本文引用的文献

1
Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.哮喘-慢性阻塞性肺疾病重叠综合征的识别算法:西班牙慢性阻塞性肺疾病与哮喘指南之间的共识
Eur Respir J. 2017 May 1;49(5). doi: 10.1183/13993003.00068-2017. Print 2017 May.
2
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.一项针对中度低氧慢性阻塞性肺疾病患者长期吸氧的随机试验。
N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344.
3
Lung volume reduction for emphysema.肺气肿的肺减容术。
单油酸甘油酯作为一种新型纳米材料在缓解慢性肺部疾病中的研究进展与应用
J Drug Deliv Sci Technol. 2022 Aug;74:103541. doi: 10.1016/j.jddst.2022.103541. Epub 2022 Jun 23.
4
Expression and Related Mechanisms of miR-100 and TRIB2 in COPD Patients.miR-100 和 TRIB2 在 COPD 患者中的表达及相关机制。
J Healthc Eng. 2022 Apr 21;2022:6556208. doi: 10.1155/2022/6556208. eCollection 2022.
5
Identification of Dysregulated Mechanisms and Candidate Gene Markers in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中失调机制和候选基因标志物的鉴定。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 4;17:475-487. doi: 10.2147/COPD.S349694. eCollection 2022.
6
To Dip or not to Dip Blood Pressure in Chronic Obstructive Pulmonary Disease: That is the Question!慢性阻塞性肺疾病患者是否存在血压波动:这是个问题!
Arq Bras Cardiol. 2021 Feb;116(2):303-304. doi: 10.36660/abc.20201379.
7
The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.慢性阻塞性肺疾病患者中慢性支气管炎表型频繁加重者和非加重者的特征:荟萃分析和系统评价。
BMC Pulm Med. 2020 Apr 23;20(1):103. doi: 10.1186/s12890-020-1126-x.
8
The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?慢性阻塞性肺疾病(COPD)合并高血压时氧化应激的严重程度:它是否取决于ACE和AGT基因多态性?
J Med Life. 2019 Oct-Dec;12(4):426-434. doi: 10.25122/jml-2019-0108.
9
The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review.慢性阻塞性肺疾病患者中具有慢性支气管炎表型和哮喘-慢性阻塞性肺疾病重叠综合征表型的频繁急性加重者的特征:一项荟萃分析和系统评价
Medicine (Baltimore). 2019 Nov;98(46):e17996. doi: 10.1097/MD.0000000000017996.
Lancet Respir Med. 2017 Feb;5(2):147-156. doi: 10.1016/S2213-2600(16)30221-1. Epub 2016 Sep 29.
4
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.肺功能正常的吸烟者症状的临床意义
N Engl J Med. 2016 May 12;374(19):1811-21. doi: 10.1056/NEJMoa1505971.
5
Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?对于慢性阻塞性肺疾病(COPD)患者,既往哮喘诊断是否是哮喘-慢性阻塞性肺疾病重叠综合征的可靠标准?
Int J Chron Obstruct Pulmon Dis. 2015 Sep 1;10:1745-52. doi: 10.2147/COPD.S87025. eCollection 2015.
6
β-Blockers are associated with a reduction in COPD exacerbations.β受体阻滞剂与慢性阻塞性肺疾病(COPD)急性加重次数减少有关。
Thorax. 2016 Jan;71(1):8-14. doi: 10.1136/thoraxjnl-2015-207251. Epub 2015 Aug 17.
7
Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis.慢性阻塞性肺疾病:漏诊与误诊
BMJ. 2015 Jul 1;351:h3021. doi: 10.1136/bmj.h3021.
8
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.慢性阻塞性肺疾病药物治疗的靶向治疗现状:向个性化管理迈进
Lancet. 2015 May 2;385(9979):1789-1798. doi: 10.1016/S0140-6736(15)60693-6.
9
Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.心血管风险、心肌损伤和慢性阻塞性肺疾病恶化。
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1091-9. doi: 10.1164/rccm.201306-1170OC.
10
Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.心血管药物对严重慢性阻塞性肺疾病患者死亡率的影响。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):715-20. doi: 10.1164/rccm.201208-1565OC.